Occurrence of the aacA4 gene among multidrug resistant strains of Pseudomonas aeruginosa isolated from bronchial secretions obtained from the intensive therapy unit at university hospital in Bialystok, Poland

Folia Histochemica et Cytobiologica

Volumn 50, Issue 2, 2012, Pages 322-324

  Sacha, Paweł ^a   Jaworowska, Jadwiga ^b   Ojdana, Dominika ^a   Wieczorek, Piotr ^a   Czaban, Sławomir ^a   Tryniszewska, Elzbieta ^a,b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b University Hospital of Bialystok   (Poland)

Author keywords

aacA4 gene; Antimicrobial susceptibility; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; CEFTAZIDIME; COLISTIN; GENTAMICIN; IMIPENEM; PIPERACILLIN; TICARCILLIN; TIMENTIN; TOBRAMYCIN;

AMINOGLYCOSIDE 6' N ACETYLTRANSFERASE GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BRONCHUS SECRETION; GENE IDENTIFICATION; GENETIC SUSCEPTIBILITY; NONHUMAN; POLAND; POLYMERASE CHAIN REACTION; PREVALENCE; PSEUDOMONAS AERUGINOSA;

PSEUDOMONAS AERUGINOSA;

EID: 84863922733     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2012.0043     Document Type: Article

References (12)

1. Giamarellou H. Prescribing guidelines for severe Pseudomonas infections. J Antimicrob Chemother. 2002;49:229-233.
2. Driscoll JA, Brody SL, Kollef MH. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs. 2007;67:351-368.
3. Strateva T, Yordanov D. Pseudomonas aeruginosa - a phenomenon of bacterial resistance. J Medic Microbiol. 2009;58:1133-1148.
4. Sacha P, Wieczorek P, Hauschild T et al. Metallo-beta-lactamases of Pseudomonas aeruginosa - a novel mechanism resistance to beta-lactam antibiotics. Folia Histochem Cytobiol. 2008;46:137-142.
5. Poole K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2005;49:479-487.
6. Strateva T, Ouzounova-Raykova V, Markova B, Todorova A, Marteva--Proevska Y, Mitov I. Problematic clinical isolates of Pseudomonas aeruginosa from the university hospitals in Sofia, Bulgaria: current status of antimicrobial resistance and prevailing resistance mechanisms. J Med Microbiol. 2007;56:956-963.
7. Dubois V, Arpin C, Dupart V et al. b-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres). J Antimicrob Chemother. 2008;62:316-323.
8. Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes. Drug Resist. 2010;13:151-171.
9. Hauschild T, Sacha P, Wieczorek P, Zalewska M, Kaczyńska K, Tryniszewska et al. Aminoglycosides resistance in clinical isolates of Staphylococcus aureus from a University Hospital in Bialystok, Poland. Folia Histochem Cytobiol. 2008;46: 225-228.
10. Wieczorek P, Sacha P, Hauschild T et al. The aac(6')Ib gene in Proteus mirabilis strains resistant to aminoglycosides. Folia Histochem Cytobiol. 2008;46:531-533.
11. Park YJ. Aminoglycoside Resistance in Gram-negative Bacilli. Korean J Clin Microbiol. 2009;12:57-161.
12. Page M, Heim J. Prospects for the next anti-Pseudomonas drug. Curr Opin Pharmacol. 2009;9:558-565.